TABLE 1.
The relationship of plasma exosomal hsa_circ_0015286 expression levels and clinicopathologic features of GC patients.
| Characteristics | Number | Mean ± SD | p value |
|---|---|---|---|
| Gender | 0.286 | ||
| Male | 32 | 3.24 ± 1.23 | |
| Female | 28 | 2.92 ± 1.05 | |
| Age, years | 0.159 | ||
| <60 | 23 | 3.07 ± 1.85 | |
| ≥60 | 37 | 3.72 ± 1.63 | |
| Tumor size, cm | <0.001* | ||
| <5 | 31 | 1.76 ± 0.68 | |
| ≥5 | 29 | 4.19 ± 1.59 | |
| Differentiation | 0.247 | ||
| Poor + Moderate | 40 | 2.88 ± 1.71 | |
| Well | 20 | 3.45 ± 1.92 | |
| T stage | <0.001* | ||
| T1+T2 | 27 | 2.57 ± 0.96 | |
| T3+T4 | 33 | 3.93 ± 1.42 | |
| Lymph node metastasis | <0.001* | ||
| No | 34 | 2.05 ± 1.14 | |
| Yes | 26 | 4.36 ± 1.55 | |
| CEA, ng/ml | 0.603 | ||
| <5 | 35 | 3.04 ± 1.63 | |
| ≥5 | 25 | 3.25 ± 1.39 | |
| CA19-9, U/ml | 0.162 | ||
| <35 | 38 | 2.79 ± 1.48 | |
| ≥35 | 22 | 3.37 ± 1.61 |
*Indicate significance at p < 0.05.
CEA, carcinoembryonic antigen; CA19-9, Carbohydrate antigen19-9.